Market Tracker

12/02 5:16pm ET

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

6.44
Delayed Data
As of 4:00pm ET
 +0.16 / +2.55%
Today’s Change
4.45
Today|||52-Week Range
13.08
-22.50%
Year-to-Date
Intrexon Corporation Surged 12% in November -- Here's Why
9:24am / MotleyFool.com - Paid Partner Content
3 Biotech Investing Tips That Could Earn You Thousands
Nov 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.28
Today’s open6.26
Day’s range6.06 - 6.50
Volume1,384,874
Average volume (3 months)1,869,514
Market cap$827.3M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-209.68%
Earnings growth (this year)-38.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.51%
P/E ratioNM
Price/Sales240.58
Price/Book9.47

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...0.000.00%
FWPForward Pharma A/S-0.44-2.45%
MGNXMacroGenics Inc+1.96+8.06%
INSYINSYS Therapeutics I...-0.11-0.99%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.3M
Annual profit (last year)-$120.1M
Net profit margin-2,772.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts